AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
VONOPRAZAN
9 registrations across 2 African markets— 9 active
Markets with VONOPRAZAN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| VONOPRAVIN TABLET, COATED; ORAL | 🇿🇼Zimbabwe | UTOPIA PHARMACEUTICALS | active | Apr 2031 |
| VONSECA TABLET, COATED; ORAL | 🇿🇼Zimbabwe | ORANGE HEALTH P/L | active | Mar 2031 |
| VONSECA TABLET, COATED; ORAL | 🇿🇼Zimbabwe | ORANGE HEALTH P/L | active | Mar 2031 |
| VONOPRAVIN TABLET, COATED; ORAL | 🇿🇼Zimbabwe | UTOPIA PHARMACEUTICALS | active | Jan 2031 |
| Vonofix 10 Tablets Tablet | 🇰🇪Kenya | Aristopharma Ltd | active | Oct 2029 |
| Vonofix 20 Tablets Tablet | 🇰🇪Kenya | Aristopharma Ltd | active | Oct 2029 |
| Vonoprazan Tablets 20 mg Coated Tablet | 🇰🇪Kenya | HARLEY’S LIMITED | active | Apr 2029 |
| Vonapro 20mg Tablets Film-Coated Tablet | 🇰🇪Kenya | Getz Pharma (Pvt.) Limited | active | Nov 2028 |
| Vonapro 10mg Tablets Film-Coated Tablet | 🇰🇪Kenya | Getz Pharma (Pvt.) Limited | active | Nov 2028 |
VONOPRAZAN in Africa — Regulatory Overview
VONOPRAZAN is registered across 2 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.